drugset / Trial / NCT01533766

A Safety, Efficacy Study of CombiflexOmega Versus SmofKabiven in Patients With Parenteral Nutrition

NCT01533766 ↗

Phase 3 Completed 50 enrolled JW Life Science
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the safety and efficacy of CombiflexOmega in comparison to SmofKabiven in postoperative patients requiring parenteral nutrition.

Timeline

Start
2011-08
Primary completion
2012-01
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Subject CombiflexOmega Unknown — Intravenous
Comparator SmofKabiven Unknown — Intravenous

Indications

No indication recorded.